Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-19 Prophylaxis with Hydroxychloroquine, Vitamin D, and Zinc in Danish Nursing Home Residents
2020-001363-85Phase 3Terminated
- Sponsor
- University Hospital Odense
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by University Hospital Odense. Primary endpoint: SARS-CoV-2 infection by rtPCR. Started Apr 2020; status: terminated.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001363-85.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001363-85.